Acquisition
DCMSHRIRAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
DCM Shriram reported standalone FY2026 revenue of Rs. 13,995 crore, up ~11% from Rs. 12,584 crore in FY2025. Profit after tax surged 47.8% to Rs. 837.55 crore vs Rs. 566.53 crore, driven partly by a deferred tax credit of Rs. 239.48 crore from opting into the new income tax regime. Basic EPS grew to Rs. 53.71 from Rs. 36.33. EBITDA margin expanded to 11.08% from 10.83%. Q4 standalone PAT stood at Rs. 370.99 crore. An exceptional item of Rs. 31.62 crore was reversed (net) related to new labour codes, after a Rs. 55 crore provision earlier in the year. The board recommended a final dividend of Rs. 4 per share (200%), taking total FY2026 dividend to Rs. 11.20 per share (560%), up from Rs. 9 per share. Unmodified auditor opinions were issued on both standalone and consolidated results. Hindusthan Specialty Chemicals, a wholly-owned subsidiary, will invest Rs. 101 crore to expand Formulated Resins capacity to 50K TPA, with DCM Shriram providing financial assistance of up to Rs. 100 crore. The company also sold its 50% stake in Shriram Polytech to Teknor Apex B.V. in April 2026, converting it from a subsidiary to a joint venture.
Strong bottom-line growth with PAT up ~48% and margin expansion signal operational efficiency gains. The new tax regime benefit inflated PAT; underlying earnings remain robust. Increased dividend payout is positive for shareholder returns. The subsidiary expansion in advanced materials signals growth investment. Clean audit with unmodified opinion is reassuring.